ADPT

Adaptive Biotechnologies Corp

$28.77

0.26 (0.91%) Today

— up— down

Market Cap

$4.59B+113.7%

Revenue (TTM)

$306.54M+50.1%

Net Income (TTM)

$-64,880,574

$-64,880,574

EPS (TTM)

-0.41

-0.41

Shares Out

159.06M

159.06M

Open

$28.77

$28.77

Previous Close

$28.51

$28.51

Day Range

$28.65 – $29.80

$28.65 – $29.80

52-Week Range

$12.00 – $29.96

$12.00 – $29.96

Beta

2.20

2.20

Volume

2.51M

2.51M

Avg Volume

2.70M

2.70M

Analyst Rating

Buy

Buy

Exchange

NASDAQ NMS - GLOBAL MARKET

NASDAQ NMS - GLOBAL MARKET

About ADPT

Related

News

Goldman Sachs Initiates Coverage On Adaptive Biotechnologies with Buy Rating, Announces Price Target of $35

Benzinga · 1d ago

Adaptive Biotechnologies (ADPT) Stock Could Be 26% Above Fair Value Despite Guideline Update

Yahoo · 4d ago

Adaptive Biotechnologies Highlights Role of Highly Sensitive MRD Testing in New International Myeloma Society Definition of Cure

Yahoo · 4d ago

Adaptive Biotechnologies (ADPT) Jumped, So What Is Driving Attention Now?

Yahoo · 5d ago

NCCN’s Myeloma MRD Update Spotlighting clonoSEQ Could Be A Game Changer For Adaptive Biotechnologies (ADPT)

Yahoo · 5d ago